August 8, 2025 · Form 4 insider transaction
Scorsis George bought 29,240 shares of Shuttle Pharmaceuticals Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.; One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.